Skip to main content
Premium Trial:

Request an Annual Quote

PreciseDx: Ted Diehl

PreciseDx has appointed Ted Diehl its new VP of Client Relations. He will play a crucial role in commercial development, strategic planning, and sales leadership for the New York-based developer of cancer risk stratification tests. Diehl has more than 20 years of experience in oncology and was previously with IBM Watson, Sanofi, and Genomic Health. Most recently, he was VP of commercial oncology at PreciseDx.